PreciControl HBeAg quant - Hepatitis B virus e-antigen IVD, control
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Roche Diagnostics Australia Pty Limited
Klassi:
Class 4
Manifatturat minn:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Żona terapewtika:
42008 - Hepatitis B virus e-antigen IVD, control
Indikazzjonijiet terapewtiċi:
PreciControl HBeAg quant is a ready for use control serum based on human serum in the negative concentration range and based on buffer for the positive concentration range. The controls are used for monitoring the accuracy of the Elecsys HBeAg quant immunoassay. PreciControl HBeAg quant is used for quality control of the Elecsys HBeAg quant immunoassay on cobas e immunoassay analysers.
